Oncology Focused, Patient Centric

We are committed to the development of novel and differentiated cancer therapies intended to overcome known drug resistance mechanisms in combination with standard-of-care therapies to provide improved outcomes to patients.

Our Clinical Trials
Our Clinical Trials
Hematologic Malignancies
Hematologic Malignancies
Solid Tumors
Solid Tumors
Delivering Benefit to Patients

Delivering Benefit to Patients

Our driving purpose and principle is simple: deliver novel and differentiated cancer therapies that provide improved outcomes for patients.
Patients